Abstract
Psoriatic and atherosclerotic plagues were examined using the real-time polymerase chain reaction. Expression of the FOSL1 gene proved to substantially increase in both psoriatic lesions of the skin and atherosclerotic lesions of vessels as compared with nonlesion samples.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Federman, D.G., Shelling, M., Prodanovich, S., et al., Psoriasis: An Opportunity to Identify Cardiovascular Risk, Br. J. Dermatol., 2009, vol. 160, no. 1, pp. 1–7.
Späh, F., Inflammation in Atherosclerosis and Psoriasis: Common Pathogenic Mechanisms and the Potential for an Integrated Treatment Approach, Br. J. Dermatol., 2008, vol. 159,suppl. 2, pp. 10–17.
Hansson, G.K., Robertson, A.K., and Söderberg-Nauclér, C., Inflammation and Atherosclerosis, Annu. Rev. Pathol., 2006, vol. 1, pp. 297–329.
Jiang, W.Y., Chattedee, A.D., Raychaudhuri, S.P., et al., Mast Cell Density and IL-8 Expression in Nonlesional and Lesional Psoriatic Skin, Int. J. Dermatol., 2001, vol. 40, no. 11, pp. 699–703.
Schön, M.P. and Boehncke, W.M., Psoriasis, N. Engl. J. Med., 2005, vol. 352, no. 18, pp. 1899–1912.
Boon, R.A. and Horrevoets, A.J., Key Transcriptional Regulators of the Vasoprotective Effects of Shear Stress, Hamostaseologie, 2009, vol. 29, no. 1, pp. 39–40, 41–43.
Bantel, H., Schmitz, M.L., Raible, A., et al., Critical Role of NF-kappaB and Stress-Activated Protein Kinases in Steroid Unresponsiveness, FASEB J., 2002, vol. 16, no. 13, pp. 1832–1834.
Gonsky, R., Deem, R.L., Hughes, C.C., et al., Activation of the CD2 Pathway in Lamina Propria T Cells Up-Regulates Functionally Active AP-1 Binding to the IL-2 Promoter, Resulting in Messenger RNA Transcription and IL-2 Secretion, J. Immunol., 1998, vol. 160, no. 10, pp. 4914–4922.
Shapiro, J., Cohen, A.D., David. M., et al., The Association between Psoriasis, Diabetes Mellitus, and Atherosclerosis in Israel: A Case-Control Study, J. Am. Acad. Dermatol., 2007, vol. 56, no. 4, pp. 629–634.
Turpaev, K.T., The Role of the AP-1 Transcription Factor in the Integration of Intracellular Signaling Pathways, Mol. Biol. (Moscow), 2006, vol. 40, no. 6, pp. 945–961.
Schreiber, Ì., Wang, Z.Q., Jochum, W., et al., Placental Vascularisation Requires the AP-1 Component Fra-1, Development, 2000, vol. 127, no. 22, pp. 4937–4948.
Schreiber, M., Poirier, C., Franchi, A., et al., Structure and Chromosomal Assignment of the fra-1 Gene, and its Exclusion as a Candidate Gene for oc (Osteosclerosis), Oncogene, 1997, vol. 15, pp. 1171–1178.
Adiseshaiah, P., Peddakama, S., Zhang, Q., et al., Mitogen Regulated Induction of FRA-1 Proto-Oncogene is Controlled by the Transcription Factors Binding to both Serum and TPA Response Elements, Oncogene, 2005, vol. 24, pp. 4193–4205.
Ni, Y.C., Lam, K.Y., Law, S., et al., Identification of Differentially Expressed Genes in Esophageal Squamous Cell Carcinoma (ESCC) by cDNA Expression Array: Overexpression of Fra-1, Neogenin, Id-1, and CDC25B Genes in ESCC, Clin. Cancer. Res., 2001, vol. 7, pp. 2213–222l.
Mangone, F.R., Brentani, M.M., Nonogaki, S., et al., Overexpression of Fos-Related Antigen-1 in Head and Neck Squamous Cell Carcinoma, Int. J. Exp. Pathol., 2005, vol. 86, pp. 205–212.
Ramos-Nino, M.E., Scapoli, L., Martinelli, M., et al., Microarray Analysis and RNA Silencing Link fra-1 to cd44 and c-met Expression in Mesothelioma, Cancer Res., 2003, vol. 63, pp. 3539–3545.
Ramos-Nino, M.E., Timblin, C.R., Mossman, B.T., et al., Mesothelial Cell Transformation Requires Increased AP-1 Binding Activity and ERK-Dependent Fra-1 Expression, Cancer Res., 2002, vol. 62, pp. 6065–6069.
Song, Y., Song, S., Zhang, D., et al., An Association of a Simultaneous Nuclear and Cytoplasmic Localization of Fra-1 with Breast Malignancy, BMC Cancer., 2006, vol. 28, no. 6, p. 298.
Casalino L., Bakiri, L., Talotta, F., et al., Fra-1 Promotes Growth and Survival in RAS-Transformed Thyroid Cells by Controlling Cyclin A Transcription, EMBO J., 2007, vol. 26, pp. 1878–1890.
Piruzyan, E.S., Nikol’skaya, T.A., Abdeev, R.M., et al., Components of the AP-1 Transcription Factor as Candidate Genes, Participating in the Development of Psoriasis, Mol. Biol. (Moscow), 2007, vol. 41, no. 6, pp. 1069–1080.
Piruzyan, E.S., Ishkin, A.A., Nikol’skaya, T.A., et al., Comparative Analysis of Molecular Genetic Processes in the Pathogeneses of Psoriasis and Crohn’s Disease, Mol. Biol. (Moscow), 2009, vol. 43, no. 1, pp. 175–179.
Livak, K.J. and Schmittgen, T.D., Analysis of Relative Gene Expression Data Using Realtime Quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 2001, vol. 25, no. 4, pp. 402–408.
Chandrasekar, B., Mummidi, S., Mahimainathan, L., et al., Interleukin-18-Induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-kappaB- and AP-1-Mediated Matrix Metalloproteinase-9 Expression and is Inhibited by Atorvastatin, J. Biol. Chem., 2006, vol. 281, no. 22, pp. 15099–15109.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.V. Sobolev, A.D. Zolotarenko, A.G. Soboleva, M.E. Sautin, S.A. Ilyina, M.K. Sarkisova, E.Z. Golukhova, A.M. Elkin, S.A. Bruskin, R.M. Abdeev, 2010, published in Genetika, 2010, Vol. 46, No. 1, pp. 104–110.
Rights and permissions
About this article
Cite this article
Sobolev, V.V., Zolotarenko, A.D., Soboleva, A.G. et al. Expression of the FOSL1 gene in psoriasis and atherosclerosis. Russ J Genet 46, 93–98 (2010). https://doi.org/10.1134/S102279541001014X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S102279541001014X